The Brand Name MEZO Has Generic Salt :: Mometasone 

MEZO  Is From Company AGIO PH. Priced :: Rs. 98

MEZO have Mometasone is comes under Sub class Drugs For Asthma,COPD,ARDS of  Main Class Respiratory System

Main Medicine Class:: Respiratory System  Sub Medicine Class :: Drugs For Asthma,COPD,ARDS 

Indications for Drugs ::

Allergic rhinitis, Nasal polyps, Asthma prophylaxis

Drug Dose ::

Nasal Treatment and prophylaxis of allergic rhinitis Adults: 100 mcg (2 sprays) in each nostril once daily, increased to 200 mcg into each nostril once daily if needed. Maintenance: 50 mcg in each nostril daily. Child: 2-11 yr: 50 mcg (1 spray) in each nostril daily; Child: >12 yr: 100 mcg in each nostril daily. Nasal polyps Adult: 100 mcg (2 sprays) in each nostril once daily; may increase to bid after 5-6 wk if needed. Inhalation Asthma prophylaxis Adult: Mild to moderate: Initially, 400 mcg once daily in the evening. Maintenance: 200 mcg once to bid. Severe: Initially, 400 mcg bid, then titrated to lowest effective dose once controlled. Child: Mild to moderate: Initially, 400 mcg once daily. Maintenance: 200 mcg once to bid. Severe: Initially, 400 mcg bid, then titrated to lowest effective dose once controlled.

Contraindication ::

Hypersensitivity to any of the ingredients of this preparation contraindicates its use.

Drug Precautions ::

Use with caution in active or inactive tuberculosis infection, herpes simplex virus infection of the eye, untreated infections affecting the body as a whole etc.

Drug Side Effects ::

Nasal/Oral inhalation: Headache, fatigue, depression; musculoskeletal pain, arthalgia; sinusitis, rhinitis, upper respiratory infection, pharyngitis, cough, epistaxis; viral infection, nasal and oral candidiasis; chest pain; abdominal pain, dry throat, vomiting, diarrhoea, dyspepsia, flatulence, gastroenteritis, nausea, vomiting; dysmenorrhoea; back pain, myalgia; conjunctivitis; earache, otitis media; asthma, bronchitis, dysphonia; nasal irritation, burning and septal perforation; wheezing; nasal ulcers; growth suppression.

Pregnancy category ::

3

Drug Mode of Action ::  

Mometasone depresses the formation, release and activity of endogenous inflammatory chemical mediators (e.g. kinins, histamine, liposomal enzymes and prostaglandin). It inhibits the margination and subsequent cell migration to the injury site, reverses vascular dilatation and permeability, resulting in decreased access of cells to the area of injury.

Drug Interactions ::

Increased risk of hypokalaemia with amphotericin B, potassium-wasting diuretics. Decreases hypoglycaemic effects of antidiabetic drugs. Increased serum levels with antifungals (imidazole). Increased risk of tendinopathies with fluoroquinolones.